rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

agilon health, inc.

AGL · NYSE

Health CareProviders & FacilitiesLeading

AGL stood above a rising 150-day average in 24 of the last 52 weekly readings, including each of the last 24 weeks. It is 18.6% above that average now. Providers & Facilities: 47% of its 53 stocks in an uptrend (−2 points in four weeks); Health Care: 28% (−9 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
24 in a row
Industry in uptrend
47% -2 in 4 wk
Insider buys, 12 months
$703K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
174 (+86)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 24 of 52 weeks.

21 Apr – 20 Oct
27%42%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Providers & Facilities: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$579KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months5
Sale orders, 12 months0
Buyers · sellers4 · 0
WhoDidSharesTraded
Benjamin ShakerChief Markets Officerbought18,4489 Mar 2026filed 11 Mar 2026
Girish VenkatachaliahChief Technology Officerbought18,4489 Mar 2026filed 11 Mar 2026
Denise ZamoreChief Legal Officerbought5,5359 Mar 2026filed 11 Mar 2026
Benjamin ShakerChief Markets Officerbought500,000at $0.60212 Mar 2026filed 3 Mar 2026
John William WulfDirectorbought81,000at $0.628912 Nov 2025filed 30 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders174+86 on the quarter
New · exited92 · 10
Reported value$1.8B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Clayton, Dubilier & Rice, LLCunchanged · filed 29 Jul 20264,000,000$428.7M00.0%
MORGAN STANLEYreduced · filed 13 Aug 20262,011,196$215.6M-88,255−4.2%
North Peak Capital Management, LLCreduced · filed 14 Aug 20261,485,066$159.2M-60,471−3.9%
BlackRock, Inc.added · filed 7 Aug 20261,146,520$122.9M+273,356+31.3%
AQR CAPITAL MANAGEMENT LLCreduced · filed 14 Aug 2026692,541$74.2M-282,356−29.0%
GOLDMAN SACHS GROUP INCreduced · filed 14 Aug 2026686,792$73.6M-375,444−35.3%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026525,328$56.3M-13,208−2.5%
MARSHALL WACE, LLPnew · filed 13 Aug 2026468,293$50.2M+468,293
Durable Capital Partners LPnew · filed 14 Aug 2026440,642$47.2M+440,642
D. E. Shaw & Co., Inc.reduced · filed 14 Aug 2026390,149$41.8M-352,069−47.4%
31 Mar 2023 – 30 Jun 2026
92140188Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Timothy Gertsch Company insiderChief Accounting Officer · last 16 Aug 20260 · 1
Denise Zamore Company insiderChief Legal Officer · last 1 Aug 20261 · 0
Jeffrey A. Schwaneke Company insiderChief Financial Officer · last 1 Jul 20262 · 0
Diana McKenzie Company insiderDirector · last 2 Jun 20262 · 0
John William Wulf Company insiderDirector · last 2 Jun 20262 · 3
Karen McLoughlin Company insiderDirector · last 2 Jun 20261 · 0
Ronald A. Williams Company insiderDirector · last 2 Jun 20260 · 0
Sharad Mansukani Company insiderDirector · last 2 Jun 20260 · 1
Silvana Battaglia Company insiderDirector · last 2 Jun 20261 · 0
Timothy Patrick O'Rourke Company insiderCEO & President · last 7 May 20260 · 0
Benjamin Shaker Company insiderChief Markets Officer · last 15 Apr 20264 · 39
Girish Venkatachaliah Company insiderChief Technology Officer · last 15 Apr 20263 · 0

Same industry

PACS PACS GroupLeading+19%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 2025-7.8%
Free cash flow marginFY 2025 · to 31 Dec 2025-2.0%
Debt to equityFY 2025 · to 31 Dec 20250.43×
Share count trendFY 2025 · to 19 Feb 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$173.7M
Free cash flowFY 2025 · to 31 Dec 2025−$119.0M

Analyst forecasts

No analyst forecasts yet.